论文部分内容阅读
Objective: To observe and evaluate the therapeutic efficacy and safety of TACE combined with hepatic arterial infusion chemotherapy (HAIC) with oxaliplatin (OXA), 5-fluorouracil(5Fu), and folinic acid (FA) in patients with hepatocellular carcinoma (HCC).